Millennium Management’s BioNTech BNTX Stock Holding History

Millennium Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.78M	Buy	+20,000	New	+$2.06M	﹤0.01%	3987
2025 Q3	–	Sell	-30,400	Closed	-$3.24M	–	6035
2025 Q2	$3.24M	Buy	+30,400	New	+$3.07M	﹤0.01%	3425
2025 Q1	–	Sell	-16,700	Closed	-$1.9M	–	5880
2024 Q4	$1.9M	Sell	16,700 -5,100	-23%	-$582K	﹤0.01%	3687
2024 Q3	$2.59M	Sell	21,800 -300	-1%	-$27.6K	﹤0.01%	3463
2024 Q2	$1.78M	Sell	22,100 -2,800	-11%	-$256K	﹤0.01%	3633
2024 Q1	$2.3M	Sell	24,900 -36,200	-59%	-$3.47M	﹤0.01%	3609
2023 Q4	$6.45M	Buy	61,100 +39,300	+180%	+$3.96M	﹤0.01%	2573
2023 Q3	$2.37M	Buy	21,800 +15,500	+246%	+$1.71M	﹤0.01%	3401
2023 Q2	$680K	Buy	+6,300	New	+$709K	﹤0.01%	4325
2022 Q1	–	Sell	-68,500	Closed	-$17.7M	–	6918
2021 Q4	$17.7M	Buy	68,500 +8,500	+14%	+$2.33M	0.01%	1555
2021 Q3	$16.4M	Buy	60,000 +35,000	+140%	+$11.1M	0.01%	1518
2021 Q2	$5.6M	Sell	25,000 -25,000	-50%	-$4.71M	﹤0.01%	2607
2021 Q1	$5.46M	Hold	50,000	–	–	﹤0.01%	2477
2020 Q4	$4.08M	Sell	50,000 -10,000	-17%	-$982K	﹤0.01%	2645
2020 Q3	$4.15K	Buy	+60,000	New	+$4.3M	0.01%	2005

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management's BNTX Position: Q1 2026 in Review

Millennium Management reduced its BioNTech (BNTX) stake by 87% in Q1 2026, selling an estimated $24.4M and leaving 35,372 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3430.

Millennium Management first reported a position in BNTX in Q4 2019 and has held it in 25 quarters since. The position peaked at $84.6M in Q3 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Millennium Management held 35,372 shares of BioNTech worth $3.14M as of Q1 2026.
Millennium Management sold 236,993 BioNTech shares in Q1 2026, an estimated $24.4M.
BioNTech made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3430 holding.
Millennium Management first reported a position in BioNTech in Q4 2019 and has held it in 25 quarters since.
Millennium Management's BioNTech position peaked at $84.6M in Q3 2021.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.